PHI LIFE SCIENCES LLC NPI 1437605615

NPI Information

  • NPI: 1437605615
  • Provider Name: PHI LIFE SCIENCES LLC
  • Classification: Clinical Medical Laboratory - 291U00000X
  • Entity Type: Organization
  • CLIA Number: 21D2158103
  • Address: 645 MEETING ST
    SUITE 3
    CHARLESTON, SC
    ZIP 29403
  • Phone: (888) 576-5445

Map and Directions

Get Directions

NPI Details

PHI LIFE SCIENCES LLC is a clinical medical laboratory in Charleston, SC. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. PHI LIFE SCIENCES LLC NPI is 1437605615. The provider is registered as an organization entity type and is a multi-specialty group.

The provider's business location address is:

645 MEETING ST
SUITE 3
CHARLESTON, SC
ZIP 29403-279
Phone: (888) 576-5445
Fax: (888) 738-2470

The provider's authorized official is Sawan Hurst .
The authorized official title is Ceo and has the following contact phone number (503) 752-3553.

The CLIA number assigned to this NPI record is 21D2158103 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
  • Identification of organisms by genetic analysis, amplified probe technique (HCPCS:87150)
  • Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
  • 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
  • Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
  • Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
  • Quantitative measurement of severe acute respiratory syndrome coronavirus 2 (covid-19] antibody (HCPCS:86413)
  • Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
  • Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled (HCPCS:P9603)
  • Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
  • Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
  • Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
  • Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
  • Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:86409)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Test for detecting genes associated with colon cancer, promoter methylation analysis (HCPCS:81288)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
  • Magnesium level (HCPCS:83735)
  • Phosphate level (HCPCS:84100)
  • Urine microalbumin (protein) level (HCPCS:82043)
  • Hemoglobin a1c level (HCPCS:83036)
  • Screening test for pathogenic organisms (HCPCS:87081)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Vitamin d-3 level (HCPCS:82306)
  • Hemoglobin a1c level, by device for home use (HCPCS:83037)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
  • Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis (HCPCS:81295)
  • Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants (HCPCS:81225)
  • Psa (prostate specific antigen) measurement, free (HCPCS:84154)
  • Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)

The enumeration date for this NPI number is 8/29/2016 and was last updated on 6/16/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207ZP0007XPathologyMolecular Genetic PathologyNo
2207ZP0101XPathologyAnatomic PathologyNo
3207ZP0105XPathologyClinical Pathology/Laboratory MedicineNo
4291U00000XClinical Medical LaboratoryYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.